Susquehanna maintains RXO at Neutral, raises price target to $30 from $19

Susquehanna kept its Neutral rating on RXO but raised its price target to $30 from $19, a 57.9% increase. This implies a 9.1% upside from the Oct 30 close of $27.49. Recent analyst targets for RXO range from $30 to $30.25.

Original reporting
Published Nov 2, 2026, 1:28 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 1:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Susquehanna maintains RXO at Neutral, raises price target to $30 from $19 — source image
Decision brief

The 30-second read

$RXOBullishLow
01

Why it matters

The target raise could attract new buyers and support price appreciation.

02

Market read

Analyst target upgrades are modest catalysts that can nudge stock price, especially for mid‑cap names like RXO.

03

What to watch

Potential macro headwinds or competitive pressures not addressed in the note.

Relevance 5/10Novelty 5/10Timing: today

Background

RXO is a publicly traded asset‑based freight brokerage; analyst coverage influences investor perception.

Company-level read

Ticker impact

$RXOBullishHigh confidence
Context

Susquehanna raised its price target on RXO to $30 from $19, indicating a bullish outlook.

Expected impact

likely upward pressure as investors price in the higher target

Evidence & confidence

Target increase of 57.9% signals strong confidence in the company's near‑term performance.

Market effects

May lift sentiment in the transportation/logistics sector.

Limited to US equity markets.

Minimal global impact.

Counterpoint

Target raises can be premature; price may already reflect optimism.

Key entities

  • Susquehanna

    Equity research firm that issued the price target update.

  • RXO

    US‑listed freight brokerage firm.

Related articles

$RXOMedAI 8/10

RXO stock holds at StoneX as freight rates improve ahead of CHRW deal

StoneX reiterated a Hold rating on RXO, Inc. (NYSE:RXO) after its Q3 adjusted EBITDA of $51M exceeded estimates. RXO's truckload gross profit and margins improved, with spot rates and contract pricing supporting brokerage margins. RXO's stock has surged 120% YTD. C.H. Robinson's $5.8B acquisition of RXO is pending, with mixed analyst reactions on ratings and price targets.

$RXOHigh

RXO’s earnings still coming out, had solid profitable quarter

RXO reported a profitable third quarter with adjusted EBITDA of $51 million, exceeding its forecast. Gross margin was 14.6%, up from Q2 but down from a year ago. CEO Drew Wilkerson highlighted momentum. Brokerage and truckload volumes increased, with a shift toward the spot market. LTL and Last Mile segments also saw growth. RXO's founder supports its acquisition by C.H. Robinson (CHRW).

$CHRWMedAI 8/10

C.H. Robinson leaders tackle RXO friction concerns

C.H. Robinson executives addressed concerns about operational overlap from the $5.8B RXO acquisition, citing manageable overlap and synergies. They emphasized Lean AI strategies for integration. Q3 2023 earnings showed net income of $198.5M and revenue of $5.36B, up 29.5% YoY. North American Surface Transportation and Global Forwarding segments both reported revenue and income growth.

$RXOMedAI 8/10

RXO (NYSE:RXO) exceeds Q3 2026 expectations

RXO reported Q3 2026 revenue of $1.87B, beating estimates by 2.6% and growing 31.7% year-on-year. Adjusted EPS was $0.09, a 20% beat, with adjusted EBITDA at $51M, a 15.1% beat. Operating margin improved to 0.9% from -0.5% last year, while free cash flow margin remained at 0.6%. Sales volumes increased 2% year-on-year.